Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

INTRODUCTION: Plasminogen activator inhibitor-1 (PAI-1), a major inhibitor of fibrinolysis, is associated with thrombosis, obesity, insulin resistance, dyslipidemia, and premature aging, which all are coexisting conditions of chronic obstructive pulmonary disease (COPD). The role of PAI-1 in COPD wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Waschki, Benjamin, Watz, Henrik, Holz, Olaf, Magnussen, Helgo, Olejnicka, Beata, Welte, Tobias, Rabe, Klaus F, Janciauskiene, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367764/
https://www.ncbi.nlm.nih.gov/pubmed/28356730
http://dx.doi.org/10.2147/COPD.S128689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367764/
https://www.ncbi.nlm.nih.gov/pubmed/28356730
http://dx.doi.org/10.2147/COPD.S128689

Ejemplares similares